Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
OCS
OCS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OCS News
Oculis Receives FDA Breakthrough Therapy Designation, Potential Market Exceeds $7 Billion
Jan 08 2026
Globenewswire
Oculis Receives FDA Breakthrough Therapy Designation, Potential Market Exceeds $7 Billion
Jan 08 2026
Globenewswire
Oculis Receives Breakthrough Therapy Designation, Potential Market Exceeds $7 Billion
Jan 08 2026
Yahoo Finance
US Stock Indices Hit Record Highs as Chip Stocks Rally
Jan 07 2026
NASDAQ.COM
US Stocks Rise with Chipmakers Leading Gains as Copper Prices Hit All-Time High
Jan 06 2026
NASDAQ.COM
Copper Prices Hit All-Time High, Mining Stocks Surge
Jan 06 2026
NASDAQ.COM
U.S. Stocks Rise as Microchip Technology Raises Q3 Revenue Outlook to $1.185 Billion
Jan 06 2026
Benzinga
Oculis (OCS) Receives FDA Breakthrough Therapy Designation for Privosegtor, Showing Significant Vision Improvement
Jan 06 2026
NASDAQ.COM
Oculis' Privosegtor Receives FDA Breakthrough Therapy Designation, Targeting $7 Billion Market
Jan 06 2026
Globenewswire
Oculis' Privosegtor Receives FDA Breakthrough Therapy Designation, Targeting $7 Billion Market
Jan 06 2026
Globenewswire
AeroVironment Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Friday
Dec 19 2025
Benzinga
JPMorgan Begins Coverage of Oculis Holding AG, Assigns Overweight Rating and $38 Price Target
Dec 19 2025
Yahoo Finance
Oculis Holding AG (OCS) Receives Upgrade to Buy: Key Information You Need to Know
Dec 03 2025
NASDAQ.COM
Linde Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Wednesday
Dec 03 2025
Benzinga
Earnings Report Ahead of Market Opening for November 18, 2025: HD, PDD, MDT, BIDU, ESLT, AS, BZ, JHX, BRBR, ENR, WB, OCSL
Nov 17 2025
NASDAQ.COM
Zoom Expected to Surge by 38%? Check Out 10 Leading Analyst Predictions for Tuesday
Nov 11 2025
Benzinga
Show More News
